Novo Nordisk Registers Clinical Trial Study to Compare Efficacy, Safety of Insulin Degludec/Insulin Aspart Twice Daily, Biphasic Insulin Aspart Twice Daily in Subjects with Type 2 Diabetes Mellitus.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    India Pharma News. 2015.